FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Wednesday

 

MS Relapses Common During 20-Year Period



























Image Source: DISCOVERMAGAZINE

Regardless of whether the disease was in the progressive phase or not, patients with multiple sclerosis (MS) were likely to experience relapses for the first time or relapse continuation between the ages of 27 and 47 years.

“These age limits can be utilized to guide [the] decision to initiate or continue disease-modifying treatments after progressive MS onset,” Martina Novotna, MD, of the Mayo Clinic in Rochester, Minnesota, and fellow researchers wrote in an abstract presented at the 2016 annual meeting of the American Academy of Neurology (AAN).

Dr Novotna and colleagues noted that relapses may continue after the onset of the progressive phase in 14% of patients with MS, and that even in patients with primary progressive MS, postprogression relapses can occur.

“Since ongoing relapses add to the disability burden of progressive MS patients, disease-modifying treatments can be continued or initiated during the overlapping period,” they wrote.

The researchers conducted the present study examining the overlapping period in late relapsing-remitting and early progressive phase of MS with the goal of guiding disease-modifying treatment initiation or discontinuation decisions.

The study included 964 patients from clinic- and population-based MS cohorts who were evaluated for age at first relapse, age at progressive MS onset, and age at last relapse (before or after progressive MS onset). Researchers determined the overlapping age range for relapsing-remitting and progressive phases of MS, along with the absolute lifetime risk of relapses after progressive MS onset.

Median ages were as follows: at first relapse, 32.6 years; at progressive MS onset, 45.9 years; and at last relapse, 42 years.

Results indicated that the overlap age range was 27 to 47 years.

In additional analysis, patients were grouped according to age at progressive MS onset based on mean ± standard deviation of 45.4 ± 9.5 into 55 years. The absolute lifetime risk for relapse after progressive MS onset was 18%, 17%, 13%, and 5%, respectively, with the last expected relapse for these groups occurring at ages 50, 65, 70, and 70 years, respectively.

Story Source: The above story is based on materials provided by NEUROLOGYADVISOR
Note: Materials may be edited for content and length

Labels:



Go to Newer News Go to Older News